MeSH term
Frequency | Condition_Probility | 1-Phosphatidylinositol 3-Kinase/metabolism | 2 | 0.0 |
Animals | 20 | 0.0 |
Blotting, Western | 2 | 0.0 |
CHO Cells | 2 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Cell Movement | 2 | 0.0 |
Glutathione Transferase/metabolism | 2 | 0.0 |
Hamsters | 2 | 0.0 |
Humans | 41 | 0.0 |
Integrins/metabolism | 2 | 1.0 |
Phosphorylation | 15 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Protein Binding | 10 | 0.0 |
Protein Structure, Tertiary | 7 | 0.0 |
Proteins/*chemistry/*metabolism | 3 | 9.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 15 | 0.0 |
Signal Transduction | 7 | 0.0 |
Transfection | 5 | 0.0 |
Chromosomes, Human, Pair 17/*genetics | 2 | 1.0 |
Gene Amplification | 2 | 0.0 |
Gene Dosage | 2 | 0.0 |
Gene Expression Profiling | 3 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Comparative Study | 6 | 0.0 |
Disease Progression | 2 | 0.0 |
*Gene Amplification | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 4 | 0.0 |
In Situ Hybridization, Fluorescence | 3 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Chromosomes, Human, Pair 17/genetics | 3 | 1.0 |
Male | 4 | 0.0 |
*Adaptor Proteins, Signal Transducing | 6 | 0.0 |
Female | 4 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
Amino Acids/chemistry | 2 | 1.0 |
Binding, Competitive | 2 | 0.0 |
Gene Library | 3 | 0.0 |
Ligands | 4 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Peptides/chemistry | 2 | 0.0 |
Tyrosine/metabolism | 5 | 0.0 |
src Homology Domains | 12 | 2.0 |
Gene Expression | 2 | 0.0 |
Apoptosis | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Binding Sites | 8 | 0.0 |
Substrate Specificity | 3 | 0.0 |
Mice | 6 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 2 | 0.0 |
Proteins/metabolism | 3 | 0.0 |
Signal Transduction/*physiology | 6 | 0.0 |
Proteins/*metabolism | 6 | 0.0 |
Adult | 3 | 0.0 |
Aged | 2 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Middle Aged | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
*Cell Movement | 2 | 1.0 |
Proteins/*physiology | 2 | 1.0 |
Cells, Cultured | 3 | 0.0 |
Models, Molecular | 2 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Base Sequence | 5 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
DNA, Complementary | 3 | 0.0 |
*Genes, erbB-2 | 3 | 3.0 |
RNA, Messenger/genetics | 2 | 0.0 |
Point Mutation | 2 | 0.0 |
Protein-Serine-Threonine Kinases/*metabolism | 2 | 0.0 |
Proteins/genetics/*metabolism | 4 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
*src Homology Domains | 3 | 1.0 |
DNA Primers | 2 | 0.0 |
RNA, Messenger/*metabolism | 2 | 0.0 |
Receptor, Epidermal Growth Factor/*metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 5 | 0.0 |
*Proteins/chemistry/genetics/metabolism/physiology | 2 | 100.0 |
Protein Conformation | 3 | 0.0 |
Dimerization | 2 | 0.0 |
Proteins/*chemistry/metabolism | 2 | 6.0 |
Solutions | 2 | 1.0 |
Neoplasm Staging | 2 | 0.0 |
